Page 8 - Vbi Vaccines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vbi vaccines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vbi Vaccines Today - Breaking & Trending Today

VBI Vaccines to Participate in the Jefferies Healthcare Conference

07.06.2022 - VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, VBI’s President and CEO, will participate in an analyst-led . ....

United Kingdom , United States , Jeff Baxter , Prehevbrio Prehevbri , Vaccines Inc , Company Quarterly Reports On Form , Jefferies Healthcare Conference , Jefferies Healthcare , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Business Wire , Vbi Vaccines ,

VBI Vaccines Inc. (NASDAQ:VBIV) Expected to Post Earnings of -$0.07 Per Share

Equities research analysts expect that VBI Vaccines Inc. (NASDAQ:VBIV – Get Rating) will announce ($0.07) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for VBI Vaccines’ earnings, with estimates ranging from ($0.08) to ($0.06). VBI Vaccines also reported earnings per share of ($0.07) during […] ....

Raymond James , Goldman Sachs Group Inc , Zacks Investment Research , Vaccines Inc , Highvista Strategies , Millennium Management , Toroso Investments , Get Rating , Zacks Investment , Investment Research , Vista Strategies , Sigma Investments , Sachs Group , Vbi Vaccines , Nasdaq Vbiv ,

Oppenheimer Weighs in on VBI Vaccines Inc.'s Q3 2022 Earnings (NASDAQ:VBIV)

VBI Vaccines Inc. (NASDAQ:VBIV – Get Rating) – Analysts at Oppenheimer upped their Q3 2022 earnings estimates for shares of VBI Vaccines in a report issued on Wednesday, May 11th. Oppenheimer analyst L. Gershell now expects that the biopharmaceutical company will post earnings per share of ($0.08) for the quarter, up from their previous forecast […] ....

Hong Kong , Raymond James , Russell Investments Group Ltd , Wealth Alliance Advisory Group , Zacks Investment Research , Vaccines Inc , Financial Services Group Inc , Mackenzie Financial Corp , Vbi Vaccines Inc , Hong Kong Ltd , Get Rating , Investment Research , Services Group , Alliance Advisory Group , Financial Corp , Investments Group , Kong Ltd , Vbi Vaccines , Nasdaq Vbiv , Earnings Estimates , Oppenheimer Holdings Inc ,

-$0.08 Earnings Per Share Expected for VBI Vaccines Inc. (NASDAQ:VBIV) This Quarter

Wall Street analysts expect VBI Vaccines Inc. (NASDAQ:VBIV – Get Rating) to announce earnings per share (EPS) of ($0.08) for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for VBI Vaccines’ earnings. VBI Vaccines posted earnings of ($0.07) per share in the same quarter last year, which suggests a negative year-over-year […] ....

Raymond James , Jefferies Financial Group , Mackenzie Financial Corp , Grimes Company Inc , Zacks Investment Research , Vaccines Inc , Highvista Strategies , Wall Street , Get Rating , Investment Research , Financial Corp , Vista Strategies , Sigma Investments , Vbi Vaccines , Nasdaq Vbiv ,

VBI Vaccines (NASDAQ:VBIV) Rating Increased to Hold at Zacks Investment Research

VBI Vaccines (NASDAQ:VBIV – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company’s eVLP vaccine platform allows for the design of […] ....

United Kingdom , United Kingdom General , Raymond James , Northern Trust Corp , Geode Capital Management , Cambridge Investment Research Advisors Inc , Zacks Investment Research , Vaccines Inc , Blackrock Inc , Jefferies Financial Group , Scivac Therapeutics Inc , Get Rating , Scivac Therapeutics , Financial Group , Street Corp , Capital Management , Investment Research Advisors , Trust Corp , Vbi Vaccines , Nasdaq Vbiv ,